Clinical Trial

Effect of Rhopressa on Intraocular Pressure (IOP) in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension Post-SLT

Name: Effect of Rhopressa on Intraocular Pressure (IOP) in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension Post-SLT — clinical trial record (NCT06865144)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

The purpose of this study is to collect data about how Rhopressa affects IOP in patients who have had an SLT procedure in both eyes.

Trial Details

NCT Number	NCT06865144
Lead Sponsor	East Coast Institute for Research Collaborators: Alcon, a Novartis Company, Florida Eye Specialists
Conditions	Primary Open Angle Glaucoma or Ocular Hypertension
Enrollment	70 participants
Start Date	2025-06-27
Primary Completion	2026-07-31 (estimated)
Study Completion	2026-09-01 (estimated)
Updated on ClinicalTrials.gov	2026-06-10